Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
about
sameAs
HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver ResectionObesity is Independently Associated With Increased Risk of Hepatocellular Cancer-related Mortality: A Systematic Review and Meta-Analysis.Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis.Advances and Future Directions in the Treatment of Hepatocellular CarcinomaClinical epidemiology and disease burden of nonalcoholic fatty liver disease.Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.Sleep Duration and Risk of Liver Cancer in Postmenopausal Women: The Women's Health Initiative Study.Metabolic Disorders and Cancer: Hepatocyte Store-Operated Ca2+ Channels in Nonalcoholic Fatty Liver Disease.Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice.XIAP 3'-untranslated region serves as a competitor for HMGA2 by arresting endogenous let-7a-5p in human hepatocellular carcinoma.Human Gut Microbiota and Gastrointestinal Cancer.Nonalcoholic fatty liver disease: epidemiology, pathogenesis and therapeutic implications.Copper/MYC/CTR1 interplay: a dangerous relationship in hepatocellular carcinoma.Co-exposure to benzo[a]pyrene and ethanol induces a pathological progression of liver steatosis in vitro and in vivo.Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation
P2860
Q33755269-70438900-44DA-49A8-AF91-43A64D8EA706Q36379171-43A999C7-C0ED-4EFC-97EE-E3B99E76E3C4Q39177080-3C131407-89E5-4835-9F2B-5C74D09129A0Q41531360-DCBB1351-68C4-4E6A-94E5-5F7A8C9B27F3Q47136445-6899B228-ED7E-44E0-811F-1763D8FF9C1AQ47625275-463CCB3F-7D8D-42C1-AE09-3F457ADD0AFBQ47682816-A2C9FB5B-7032-4D6A-8997-69AB2D94AB6AQ47812757-CD8D97B2-DED6-43BD-B45E-34B8C923C8E6Q49337769-39673EE6-D407-485F-B0C7-D32662C4C57DQ50900150-3F1FD56E-EC9E-45F3-B49A-C6347A4CA9E4Q52374120-77673503-BC0C-49E1-A372-A2340155E7A3Q52562619-152AA2DB-09D2-4581-A866-33E91C163777Q52672954-093A2227-1C4C-4094-95B5-E68E9F87A9EFQ55154163-153A7380-89BB-4F80-8DFA-C359F580CC4AQ57109511-5CF19389-18F4-4E6D-95F4-2A177127B09F
P2860
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
@ast
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
@en
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
@nl
type
label
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
@ast
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
@en
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
@nl
prefLabel
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
@ast
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
@en
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
@nl
P2860
P921
P3181
P356
P1476
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
@en
P2093
Joseph K Lim
Mindie H Nguyen
P2860
P304
P3181
P356
10.3748/WJG.V22.I37.8294
P407
P5008
P577
2016-10-07T00:00:00Z